The Administrative Core is the central command and operations post of the Liver Pathobiology and Gene Therapy Research Core Center. The Core maintains and manages the fundamental infrastructure necessary to sustain and strengthen basic translational and clinical liver-related research at the Center. All planning, communications and activities of the Center go through this office. Dr. Allan W. Wolkoff, Director of the Center is Director of the Administrative Core. He is assisted by the Associate Director, David A. Shafritz, who oversees operation of the Research Core Facilities and our Administrator, who manages the Core Center grant and grants submitted by Center Investigators. She assists in preparation of all budgets and personnel assigned to grants flowing through the Center;in addition, she manages expenditures by the Core Facilities, Pilot and Feasibility Studies and the Enrichment Program. Four key committees, 1) the Executive Committee, 2) the Scientific Advisory Committee, 3) the Core Facilities Management Committee and the 4) Educational and Enrichment Committee work to ensure smooth operations of the Center and assure outstanding program management and effective operation. Working together, under the outstanding vision and leadership of the Director, and with continued support from NIDDK, Albert Einstein College of Medicine and Montefiore Medical Center, the Pathobiology and Gene Therapy Research Core Center enthusiastically looks forward to achieving major advances in liver pathobiology and treatment of liver diseases, during the next funding period.
It is estimated that over 30 million Americans have a liver disorder;further, liver disease is one of the ten leading causes of death in the United States. Although advances have been made in diagnosis and treatment of liver diseases, there is still much to be learned. The Liver Research Center at Einstein provides a multidisciplinary approach to the study of liver disease by integrating basic and clinical research efforts to foster development of new insights and paradigms.
|Walters, Ryan O; Arias, Esperanza; Diaz, Antonio et al. (2018) Sarcosine Is Uniquely Modulated by Aging and Dietary Restriction in Rodents and Humans. Cell Rep 25:663-676.e6|
|Liu, Zhongbo; Apontes, Pasha; Fomenko, Ekaterina V et al. (2018) Mangiferin Accelerates Glycolysis and Enhances Mitochondrial Bioenergetics. Int J Mol Sci 19:|
|Tekirdag, Kumsal; Cuervo, Ana Maria (2018) Chaperone-mediated autophagy and endosomal microautophagy: Joint by a chaperone. J Biol Chem 293:5414-5424|
|Zhao, Rongbao; Najmi, Mitra; Aluri, Srinivas et al. (2018) Concentrative Transport of Antifolates Mediated by the Proton-Coupled Folate Transporter (SLC46A1); Augmentation by a HEPES Buffer. Mol Pharmacol 93:208-215|
|Amengual, Jaume; Guo, Liang; Strong, Alanna et al. (2018) Autophagy Is Required for Sortilin-Mediated Degradation of Apolipoprotein B100. Circ Res 122:568-582|
|Schneider, Michael; Kumar, Vivek; Nordstrøm, Lars Ulrik et al. (2018) Inhibition of Delta-induced Notch signaling using fucose analogs. Nat Chem Biol 14:65-71|
|Iqbal, Niloy Jafar; Lu, Zhonglei; Liu, Shun Mei et al. (2018) Cyclin-dependent kinase 4 is a preclinical target for diet-induced obesity. JCI Insight 3:|
|Galsgaard, Katrine D; Winther-Sørensen, Marie; Ørskov, Cathrine et al. (2018) Disruption of glucagon receptor signaling causes hyperaminoacidemia exposing a possible liver-alpha-cell axis. Am J Physiol Endocrinol Metab 314:E93-E103|
|Shen, Ling; Liu, Yin; Tso, Patrick et al. (2018) Silencing steroid receptor coactivator-1 in the nucleus of the solitary tract reduces estrogenic effects on feeding and apolipoprotein A-IV expression. J Biol Chem 293:2091-2101|
|Dulyaninova, Natalya G; Ruiz, Penelope D; Gamble, Matthew J et al. (2018) S100A4 regulates macrophage invasion by distinct myosin-dependent and myosin-independent mechanisms. Mol Biol Cell 29:632-642|
Showing the most recent 10 out of 451 publications